STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

Intercept to Present at the 2021 RBC Capital Markets Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Intercept Pharmaceuticals (Nasdaq: ICPT) has announced that CEO Jerry Durso will present at the 2021 RBC Capital Markets Global Healthcare Conference on May 19, 2021, at 4:50 p.m. ET. This conference is a significant event for the biopharmaceutical company, which specializes in novel therapeutics for progressive non-viral liver diseases such as primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). A live webcast of the presentation will be available on their investor page, with an audio archive accessible for two weeks thereafter.

Positive
  • None.
Negative
  • None.

NEW YORK, May 12, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer of Intercept, will present at the 2021 RBC Capital Markets Global Healthcare Conference on Wednesday, May 19, 2021 at 4:50 p.m. ET.

A live webcast of the event will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. An audio archive of the webcast will also be available on Intercept’s website for approximately two weeks.

About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.

CONTACT

For more information about Intercept, please contact:

Investor inquiries: investors@interceptpharma.com

Media inquiries: media@interceptpharma.com

Source: Intercept Pharmaceuticals, Inc.


FAQ

What is Intercept Pharmaceuticals presenting at the RBC Capital Markets Global Healthcare Conference on May 19, 2021?

Intercept Pharmaceuticals will have CEO Jerry Durso presenting at the conference.

Where can I watch the Intercept Pharmaceuticals presentation from the RBC conference?

You can watch the presentation live on Intercept's investor page.

What time does the Intercept Pharmaceuticals presentation start at the RBC Capital Markets Global Healthcare Conference?

The presentation starts at 4:50 p.m. ET.

How long will the audio archive of the Intercept Pharmaceuticals presentation be available?

The audio archive will be available for approximately two weeks after the event.

What diseases does Intercept Pharmaceuticals focus on treating?

Intercept Pharmaceuticals focuses on treating progressive non-viral liver diseases, including PBC and NASH.

Intercept Pharmaceuticals, Inc.

NASDAQ:ICPT

ICPT Rankings

ICPT Latest News

ICPT Stock Data

794.69M
40.45M
3.13%
81.3%
24.24%
Biotechnology
Healthcare
Link
United States
Morristown